Literature DB >> 21409446

Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.

Mikako Ito1, Yuko Katakai, Fumiko Ono, Hirofumi Akari, Ryo-Zabro Mukai, Tomohiko Takasaki, Akira Kotaki, Ichiro Kurane.   

Abstract

Neutralizing antibody responses were examined in monkeys after dengue virus infections. In monkeys that had been infected once or twice with DENV-2, neutralizing antibody was cross-reactive with all four serotypes after secondary or tertiary infection with DENV-3. In monkeys that had been inoculated with DENV-1 and DENV-2 in the primary and secondary infections, neutralizing antibody titers did not increase after tertiary infection with DENV-3. These results indicate that antibody responses after secondary and tertiary infections with different serotypes are cross-reactive with all four serotypes, consistent with what has been observed in humans, and suggest that monkeys are useful for determining neutralizing antibody responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21409446     DOI: 10.1007/s00705-011-0959-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

1.  Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus.

Authors:  Meng Ling Moi; Yasushi Ami; Kenji Shirai; Chang-Kweng Lim; Yuriko Suzaki; Yuka Saito; Kazutaka Kitaura; Masayuki Saijo; Ryuji Suzuki; Ichiro Kurane; Tomohiko Takasaki
Journal:  Am J Trop Med Hyg       Date:  2014-12-29       Impact factor: 2.345

Review 2.  Human antibody response to dengue virus: implications for dengue vaccine design.

Authors:  Meng Ling Moi; Tomohiko Takasaki; Ichiro Kurane
Journal:  Trop Med Health       Date:  2016-03-14

3.  Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.

Authors:  Meihui Xu; Roland Züst; Ying Xiu Toh; Jennifer M Pfaff; Kristen M Kahle; Edgar Davidson; Benjamin J Doranz; Sumathy Velumani; Farhana Tukijan; Cheng-I Wang; Katja Fink
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

4.  Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.

Authors:  Veronique Barban; Nathalie Mantel; Aymeric De Montfort; Anke Pagnon; Fabrine Pradezynski; Jean Lang; Florence Boudet
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

Review 5.  Non-Human Primate Models of Dengue Virus Infection: A Comparison of Viremia Levels and Antibody Responses during Primary and Secondary Infection among Old World and New World Monkeys.

Authors:  Nor Azila Muhammad Azami; Tomohiko Takasaki; Ichiro Kurane; Meng Ling Moi
Journal:  Pathogens       Date:  2020-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.